Virtu Financial LLC Pasithea Therapeutics Corp. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.44 - $0.63 $642 - $919	-1,460 Reduced 8.62%	15,469 $7,000
Q2 2023 Jul 27, 2023	BUY	$0.31 - $0.5 $640 - $1,032	2,065 Added 13.89%	16,929 $8,000
Q1 2023 May 01, 2023	SELL	$0.38 - $0.73 $6,107 - $11,733	-16,073 Reduced 51.95%	14,864 $6,000
Q4 2022 Feb 15, 2023	BUY	$0.55 - $26.0 $17,015 - $804,362	30,937 New	30,937 $20,000
Q2 2022 Aug 09, 2022	BUY	$16.52 - $27.0 $240,712 - $393,417	14,571 New	14,571 $15,000

Ticker KTTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,398,700
Market Cap $157M
Description
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.